Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production: Notice of Request for Statements on the Public Interest, 39456-39457 [2017-17468]
Download as PDF
39456
Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices
appearance in the preliminary phase of
the investigation need not enter a
separate appearance for the final phase
of the investigation. Industrial users,
and, if the merchandise under
investigation is sold at the retail level,
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to the investigation.
Background
mstockstill on DSK30JT082PROD with NOTICES
On June 28, 2017, The Timken
Company, North Canton, Ohio, filed a
petition with the Commission and
Commerce, alleging that an industry in
the United States is materially injured
by reason of LTFV imports of tapered
roller bearings from Korea. Accordingly,
effective June 28, 2017, the Commission,
pursuant to section 733(a) of the Act (19
U.S.C. 1673b(a)), instituted antidumping
duty investigation No. 731–TA–1380
(Preliminary).
Notice of the institution of the
Commission’s investigation and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of July 5, 2017 (82 FR
31067). The conference was held in
Washington, DC, on July 19, 2017, and
all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission made this
determination pursuant to section
733(a) of the Act (19 U.S.C. 1673b(a)). It
completed and filed its determination in
this investigation on August 14, 2017.
The views of the Commission are
contained in USITC Publication 4721
(August 2017), entitled Tapered Roller
Bearings from Korea: Investigation No.
731–TA–1380 (Preliminary).
By order of the Commission.
Issued: August 14, 2017.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2017–17467 Filed 8–17–17; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
17:47 Aug 17, 2017
Jkt 241001
Section 337 of the Tariff Act of 1930
provides that if the Commission finds a
violation it shall exclude the articles
concerned from the United States:
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1005]
Certain L-Tryptophan, L-Tryptophan
Products, and Their Methods of
Production: Notice of Request for
Statements on the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the presiding administrative law judge
has issued a Final Initial Determination
and Recommended Determination on
Remedy and Bonding in the abovecaptioned investigation. This notice is
soliciting public interest comments from
the public only. Parties are to file public
interest submissions pursuant to
Commission rules.
FOR FURTHER INFORMATION CONTACT:
Houda Morad, Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202)
708–4716. The public version of the
complaint can be accessed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov, and will be
available for inspection during official
business hours (8:45 a.m. to 5:15 p.m.)
in the Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW., Washington, DC 20436,
telephone (202) 205–2000.
General information concerning the
Commission may also be obtained by
accessing its Internet server (https://
www.usitc.gov). The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. Hearingimpaired persons are advised that
information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission is soliciting comments on
public interest issues raised by the
recommended relief, should the
Commission find a violation,
specifically: (1) A limited exclusion
order (‘‘LEO’’) against certain Ltryptophan, L-tryptophan products, and
their methods of production, which are
imported, sold for importation, and/or
sold after importation by Respondents
CJ CheilJedang Corp. of Seoul, Republic
of Korea, CJ America, Inc. (‘‘CJ
America’’) of Downers Grove, Illinois,
and PT CheilJedang Indonesia of Jakarta,
Indonesia (collectively ‘‘CJ’’ or
‘‘Respondents’’); and (2) a cease and
desist order (‘‘CDO’’) against
Respondent CJ America.
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
unless, after considering the effect of such
exclusion upon the public health and
welfare, competitive conditions in the United
States economy, the production of like or
directly competitive articles in the United
States, and United States consumers, it finds
that such articles should not be excluded
from entry.
19 U.S.C. 1337(d)(1). A similar
provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in
further development of the record on
the public interest in these
investigations. Accordingly, parties are
to file public interest submissions
pursuant to pursuant to 19 CFR
210.50(a)(4). In addition, members of
the public are hereby invited to file
submissions of no more than five (5)
pages, inclusive of attachments,
concerning the public interest in light of
the administrative law judge’s
Recommended Determination on
Remedy and Bonding issued in this
investigation on August 11, 2017.
Comments should address whether
issuance of the LEO and CDO in this
investigation, should the Commission
find a violation, would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the recommended
orders are used in the United States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the recommended orders;
(iii) identify like or directly
competitive articles that complainants,
their licensees, or third parties make in
the United States which could replace
the subject articles if they were to be
excluded;
(iv) indicate whether complainants,
complainants’ licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the recommended
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the LEO and CDO
would impact consumers in the United
States.
Written submissions from the public
must be filed no later than by close of
business on Wednesday, September 20,
2017.
E:\FR\FM\18AUN1.SGM
18AUN1
Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to section
210.4(f) of the Commission’s Rules of
Practice and Procedure (19 CFR
210.4(f)). Submissions should refer to
the investigation number (‘‘Inv. No.
337–TA–1005’’) in a prominent place on
the cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, https://www.usitc.gov/
secretary/fed_reg_notices/rules/
handbook_on_electronic_filing.pdf).
Persons with questions regarding filing
should contact the Secretary (202–205–
2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
any confidential filing. All nonconfidential written submissions will be
available for public inspection at the
Office of the Secretary and on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of sections 201.10 and 210.50 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.50).
By order of the Commission.
Issued: August 14, 2017.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2017–17468 Filed 8–17–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–NEW]
mstockstill on DSK30JT082PROD with NOTICES
Agency Information Collection
Activities;
Proposed eCollection eComments
Requested; DEA Ambassador Program
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-day Notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration, will be submitting the
SUMMARY:
VerDate Sep<11>2014
17:47 Aug 17, 2017
Jkt 241001
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. This proposed
information collection was previously
published in the Federal Register at 82
FR 28355, on June 21, 2017, allowing for
a 60-day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
September 18, 2017.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Gary R. Owen, Chief, Office of
Congressional & Public Affairs, Drug
Enforcement Administration, 8701
Morrissette Drive, Springfield, VA
22152. Written comments and/or
suggestions can also be sent to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention: Department of Justice
Desk Officer, Washington, DC 20503 or
sent to OIRA_submissions@
omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Proposed collection.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
39457
2. The Title of the Form/Collection:
DEA Ambassador Program (DAP)
Volunteer Application.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form number is DEA–320. The
applicable component within the
Department of Justice is the Drug
Enforcement Administration.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals. The
Ambassador Program is designed to
enhance the ability of the DEA Field
Divisions to cultivate and leverage
community relationships for the
purpose of increasing illicit drug
prevention and education strategies.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 100
respondents will complete the
application in approximately 10
minutes.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 16.6
hours. It is estimated that applicants
will take 10 minutes to complete the
DEA–320. The burden hours for
collecting respondent data sum to 1,000
hours (100 respondents × 10 minutes =
1,000 hours). 1,000/60 seconds = 16.6.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N street NE., 3E.405B,
Washington, DC 20530.
Dated: August 15, 2017.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2017–17469 Filed 8–17–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On August 14, 2017, the Department
of Justice lodged a proposed Consent
Decree (‘‘Consent Decree’’) with the
United States District Court for the
District of Connecticut in the lawsuit
entitled United States v. City of
Waterbury, CT and Synagro Northeast,
LLC, Civil Action No. 2:17–cv–01377.
In a Complaint, the United States, on
behalf of the U.S. Environmental
Protection Agency (‘‘EPA’’), alleges that
E:\FR\FM\18AUN1.SGM
18AUN1
Agencies
[Federal Register Volume 82, Number 159 (Friday, August 18, 2017)]
[Notices]
[Pages 39456-39457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17468]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1005]
Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of
Production: Notice of Request for Statements on the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the presiding administrative law
judge has issued a Final Initial Determination and Recommended
Determination on Remedy and Bonding in the above-captioned
investigation. This notice is soliciting public interest comments from
the public only. Parties are to file public interest submissions
pursuant to Commission rules.
FOR FURTHER INFORMATION CONTACT: Houda Morad, Office of the General
Counsel, U.S. International Trade Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202) 708-4716. The public version of
the complaint can be accessed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov, and will be available for inspection
during official business hours (8:45 a.m. to 5:15 p.m.) in the Office
of the Secretary, U.S. International Trade Commission, 500 E Street
SW., Washington, DC 20436, telephone (202) 205-2000.
General information concerning the Commission may also be obtained
by accessing its Internet server (https://www.usitc.gov). The public
record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission is soliciting comments on
public interest issues raised by the recommended relief, should the
Commission find a violation, specifically: (1) A limited exclusion
order (``LEO'') against certain L-tryptophan, L-tryptophan products,
and their methods of production, which are imported, sold for
importation, and/or sold after importation by Respondents CJ
CheilJedang Corp. of Seoul, Republic of Korea, CJ America, Inc. (``CJ
America'') of Downers Grove, Illinois, and PT CheilJedang Indonesia of
Jakarta, Indonesia (collectively ``CJ'' or ``Respondents''); and (2) a
cease and desist order (``CDO'') against Respondent CJ America.
Section 337 of the Tariff Act of 1930 provides that if the
Commission finds a violation it shall exclude the articles concerned
from the United States:
unless, after considering the effect of such exclusion upon the
public health and welfare, competitive conditions in the United
States economy, the production of like or directly competitive
articles in the United States, and United States consumers, it finds
that such articles should not be excluded from entry.
19 U.S.C. 1337(d)(1). A similar provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in further development of the record
on the public interest in these investigations. Accordingly, parties
are to file public interest submissions pursuant to pursuant to 19 CFR
210.50(a)(4). In addition, members of the public are hereby invited to
file submissions of no more than five (5) pages, inclusive of
attachments, concerning the public interest in light of the
administrative law judge's Recommended Determination on Remedy and
Bonding issued in this investigation on August 11, 2017. Comments
should address whether issuance of the LEO and CDO in this
investigation, should the Commission find a violation, would affect the
public health and welfare in the United States, competitive conditions
in the United States economy, the production of like or directly
competitive articles in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the recommended
orders are used in the United States;
(ii) identify any public health, safety, or welfare concerns in the
United States relating to the recommended orders;
(iii) identify like or directly competitive articles that
complainants, their licensees, or third parties make in the United
States which could replace the subject articles if they were to be
excluded;
(iv) indicate whether complainants, complainants' licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the recommended exclusion order and/or
a cease and desist order within a commercially reasonable time; and
(v) explain how the LEO and CDO would impact consumers in the
United States.
Written submissions from the public must be filed no later than by
close of business on Wednesday, September 20, 2017.
[[Page 39457]]
Persons filing written submissions must file the original document
electronically on or before the deadlines stated above and submit 8
true paper copies to the Office of the Secretary by noon the next day
pursuant to section 210.4(f) of the Commission's Rules of Practice and
Procedure (19 CFR 210.4(f)). Submissions should refer to the
investigation number (``Inv. No. 337-TA-1005'') in a prominent place on
the cover page and/or the first page. (See Handbook for Electronic
Filing Procedures, https://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf). Persons with questions
regarding filing should contact the Secretary (202-205-2000).
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. A
redacted non-confidential version of the document must also be filed
simultaneously with any confidential filing. All non-confidential
written submissions will be available for public inspection at the
Office of the Secretary and on EDIS.
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of sections 201.10
and 210.50 of the Commission's Rules of Practice and Procedure (19 CFR
201.10, 210.50).
By order of the Commission.
Issued: August 14, 2017.
William R. Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2017-17468 Filed 8-17-17; 8:45 am]
BILLING CODE 7020-02-P